In select lung cancer cell lines, CX3CR1 signals through the Src/FAK axis to promote both migration and invasion in transwell and Matrigel assays, and this was blocked by saracatinib, a small molecule inhibitor of Src family kinases 137. Here, CX3CR1 is linked to lung cancer.